MedPath

A Study on the Human Application for the Prevention of Implant Peripheral Inflammation by Intake of probiotics Weissella cibaria CM

Not Applicable
Recruiting
Conditions
Diseases of the digestive system
Registration Number
KCT0007978
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

Patients visiting the hospital with peri-implant inflammation
• A person who agrees to the study and is able to communicate
• Adults over 20 and under 70 with good overall health
• Those with mild to moderate inflammation and PPD exceeding 5 mm, bleeding or suppression upon probe, and loss of limbic bone exceeding 2 mm
• A person who has agreed to periodontal therapy (gingival curattage) after local anesthesia for the area of inflammation around the implant
• If there are multiple areas of inflammation around the implant in one person, select the worst area

Exclusion Criteria

• a person with an uncontrolled systemic disease
• A person who has taken antibiotics within one month of visit 1 or is likely to take antibiotics during the study period;
• Pregnant women or nursing women
• People with acute symptoms around the prosthesis
• A person who is sensitive to lactobacillus products including dairy products or has allergies (rhinitis, rash, diarrhea, abdominal pain, vomiting, itching, etc.)
• A person who has consumed lactobacillus-containing food or health functional food within one week of the first visit;

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding on probing (BOP)
Secondary Outcome Measures
NameTimeMethod
Gingival index (GI);Periodontal pocket depth (PD);Plaque inex (PI);oral microbiome
© Copyright 2025. All Rights Reserved by MedPath